Neuropathy and Efficacy Of Weekly Subcutaneous Bortezomib In Myeloma and AL Amyloidosis

被引：1
|
作者：
Sidana, Surbhi
Faiman, Beth
Elson, Paul
Smith, Mitchell R.
Dean, Robert M.
Valent, Jason
Samaras, Christy
Duong, Hien K.
Hastings, Debbie
Bruening, Kellie
Reu, Frederic J.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1975.1975
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1975
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients
    Takezako, Naoki
    Tokuhira, Michihide
    Sekiguchi, Naohiro
    Kurihara, Yuya
    Ito, Kenichi
    Kurimoto, Miwa
    Suzuki, Kenshi
    Kizaki, Masahiro
    [J]. BLOOD, 2016, 128 (22)
  • [32] Efficacy and safety of subcutaneous versus intravenous bortezomib in multiple myeloma: a meta-analysis
    Hu, Bin
    Zhou, Quan
    Wu, Tao
    Zhuang, Lan
    Yi, Liping
    Cao, Jinxia
    Yang, Xin
    Wang, Jun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (04) : 329 - 338
  • [33] Safety and efficacy of subcutaneous formulation of bortezomib versus the conventional intravenous formulation in multiple myeloma
    Mateos, Maria-Victoria
    San Miguel, Jesus F.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) : 117 - 124
  • [34] Efficacy of Subcutaneous Bortezomib in the Management of Patients with Multiple Myeloma or Relapsed Mantle Cell Lymphoma
    Podar, Klaus
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2014, 6 : 15 - 23
  • [35] COMPARATIVE EFFICACY OF SUBCUTANEOUS AND INTRAVENOUS ADMINISTRATION OF BORTEZOMIB IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Skvortsova, N.
    Pospelova, T.
    Kovynev, I.
    Nechunaeva, I.
    [J]. HAEMATOLOGICA, 2014, 99 : 657 - 657
  • [36] Efficacy and safety study of subcutaneous injection of bortezomib in the treatment of de novopatients with multiple myeloma
    刘辉
    [J]. China Medical Abstracts (Internal Medicine), 2013, 30 (04) : 229 - 230
  • [37] The Weekly Infusion of Bortezomib Reduces Peripheral Neuropathy.
    Gay, Francesca
    Bringhen, Sara
    Genuardi, Mariella
    Rossi, Davide
    Ria, Roberto
    Romano, Alessandra
    Ferrara, Felicetto
    Di Renzo, Nicola
    Dominietto, Alida
    Andriani, Alessandro
    Rizzi, Rita
    Vallone, Roberto
    Mele, Giuseppe
    Storti, Sergio
    Podda, Luigi
    Aitoro, Gabriele
    Mettivier, Vincenzo
    Annibali, Ombretta
    Rossini, Fausto
    Gentilini, Patrizia
    Pavone, Vincenzo
    Giuliani, Nicola
    Rauco, Anna Maria
    Baraldi, Anna
    Capaldi, Antonio
    Gherlinzoni, Filippo
    Gaidano, Gianluca
    Boccadoro, Mario
    Palumbo, Antonio
    [J]. BLOOD, 2009, 114 (22) : 1495 - 1496
  • [38] Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
    Reece, Donna E.
    Sanchorawala, Vaishali
    Hegenbart, Ute
    Merlini, Giampaolo
    Palladini, Giovanni
    Fermand, Jean-Paul
    Vescio, Robert A.
    Liu, Xiangyang
    Elsayed, Yusri A.
    Cakana, Andrew
    Comenzo, Raymond L.
    [J]. BLOOD, 2009, 114 (08) : 1489 - 1497
  • [39] Bortezomib for AL amyloidosis: moving forward
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    [J]. BLOOD, 2011, 118 (04) : 827 - 828
  • [40] Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
    Brioli, Annamaria
    Zannetti, Beatrice Anna
    Zamagni, Elena
    Tacchetti, Paola
    Pantani, Lucia
    Mancuso, Katia
    Pezzi, Annalisa
    Rocchi, Serena
    Cavo, Michele
    [J]. HAEMATOLOGICA, 2014, 99 (11)
12345